Wyszukiwarka
Cell Density-Dependent Cytological Stage Profile and Its Application for a Screen of Cytostatic Agents Active Toward Leukemic Stem Cells
Abstrakt
Proliferation and expansion of leukemia is driven by leukemic stem cells (LSCs). Multidrug resistance (MDR) of LSCs is one of the main reasons of failure and relapses in acute myeloid leukemia (AML) treatment. In this study, we show that maintaining HL-60 at low cell culture density or applying a 240-day treatment with anthrapyridazone (BS-121) increased the percentage of primitive cells, which include LSCs determining the overall stage profile. This change manifested in morphology, expression of both cell surface markers and redox-state proteins, as well as mitochondrial potential. Moreover, four sublines were generated, each with unique and characteristic stage profile and cytostatic sensitivity. Cell density-induced culture alterations (affecting stage profiles) were exploited in a screen of anthrapyridazones. Among the compound tested, C-123 was the most potent against primitive cell stages while generating relatively low amounts of reactive oxygen species (ROS). Furthermore, it had low toxicity in vivo and weakly affected blood morphology of healthy mice. The cell density-dependent stage profiles could be utilized in preliminary drug screens for activity against LSCs or in construction of patient-specific platforms to find drugs effective in case of AML relapse (drug extrapolation). The correlation between ROS generation in differentiated cells and toxic effect observed in HL-60 has a potential application in myelotoxicity predictions. The discovered properties of C-123 indicate its potential application in AML treatment, specifically in conditioned myeloablation preceding allogeneic transplantation and/or ex vivo treatment preceding autologous transplantation.
Cytowania
-
5
CrossRef
-
0
Web of Science
-
5
Scopus
Autorzy (12)
-
Grzegorz Jan Grabe dr
- Imperial College London, Faculty of Medicine Department of Medicine
-
Marta Switalska
- Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk Zakład Onkologii Doświadczalnej
-
Joanna Wietrzyk
- Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk Zakład Onkologii Doświadczalnej
-
Andrzej Hellmann prof. dr hab. n. med.
- Gdański Uniwersytet Medyczny, Wydział Lekarski Katedra i Klinika Hematologii i Transplantologii
Cytuj jako
Pełna treść
pełna treść publikacji nie jest dostępna w portalu
Słowa kluczowe
Informacje szczegółowe
- Kategoria:
- Publikacja w czasopiśmie
- Typ:
- artykuł w czasopiśmie wyróżnionym w JCR
- Opublikowano w:
-
STEM CELLS AND DEVELOPMENT
nr 27,
wydanie 7,
strony 488 - 513,
ISSN: 1547-3287 - Język:
- angielski
- Rok wydania:
- 2018
- Opis bibliograficzny:
- Lica J., Grabe G., Heldt M., Misiak M., Bloch P., Serocki M., Switalska M., Wietrzyk J., Bagiński M., Hellmann A., Borowski E., Składanowski A.: Cell Density-Dependent Cytological Stage Profile and Its Application for a Screen of Cytostatic Agents Active Toward Leukemic Stem Cells// STEM CELLS AND DEVELOPMENT. -Vol. 27, iss. 7 (2018), s.488-513
- DOI:
- Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.1089/scd.2017.0245
- Weryfikacja:
- Politechnika Gdańska
wyświetlono 134 razy
Publikacje, które mogą cię zainteresować
Effective Drug Concentration and Selectivity Depends on Fraction of Primitive Cells
- J. Lica,
- M. Wieczór,
- G. J. Grabe
- + 11 autorów
Conjugates of Ciprofloxacin and Levofloxacin with Cell-Penetrating Peptide Exhibit Antifungal Activity and Mammalian Cytotoxicity
- N. Ptaszyńska,
- K. Gucwa,
- K. Olkiewicz
- + 10 autorów